• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Tiptipot Simicol
    / CTS


    Active Ingredient
    Simethicone 40 mg/ 0.6 ml

    Status in Israel
    OTC

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Oral Drops

    30 ml

    not in the basket chart 28691 20332

    Oral Drops

    30 ml + Babybook

    not in the basket chart 71219 20603

    Oral Drops

    30 ml + Doll

    not in the basket chart 70701 20604

    Related information


    Dosage

    Recommended Dosage: 0.3 ml (20 mg) before each meal. Dosage may be increased to 0.6 ml (40 mg) if required. Do not exceed 12 doses of 0.3 ml or 6 doses of 0.6 ml (totaling 240 mg) a day.


    Indications

    Antiflatulent for relief of gripping pain, infant colic or wind due to swallowed air.


    Contra-Indications

    Hypersensitivity to the active substance or any of its excipients.


    Special Precautions

    None stated.


    Side Effects

    See prescribing information for full details.


    Drug interactions

    Levothyroxine may bind to simeticone. Absorption of levothyroxine may be impaired if Tiptipot Simicol are given concurrently to infants treated for thyroid disorders.


    Pregnancy and Lactation

    As simeticone is not absorbed, it is not anticipated that this medicinal product will have any adverse effects on pregnancy and lactation. However, as with all drugs, caution should be exercised in these conditions.


    Overdose

    No cases of overdose have been reported. Theoretically, constipation may occur. Treat with fluids and keep under observation.


    Manufacturer
    CTS Chemical Industries Ltd
    CLOSE